-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Updates on Genetic Drivers of Histiocyte Disorders

Program: Spotlight Sessions
Session: New Horizons for Histiocyte Disorders
Sunday, December 11, 2022, 4:30 PM-5:45 PM

Carl E. Allen, MD

Texas Children’s Hospital, Texas Children's Cancer Center, Houston, TX; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX

Disclosures: Allen: sobi: Consultancy.

Previous Presentation | Next Presentation >>